Alpine Global Management, LLC Iveric Bio, Inc. Transaction History

Alpine Global Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 06, 2024	BUY	$26.24 - $39.63 $196,800 - $297,225	7,500 New	7,500 $295,000
Q2 2023 Nov 21, 2023	BUY	$26.24 - $39.63 $196,800 - $297,225	7,500 New	7,500 $295,000
Q2 2023 Aug 14, 2023	BUY	$26.24 - $39.63 $196,800 - $297,225	7,500 New	7,500 $295,000
Q1 2022 May 13, 2022	SELL	$12.15 - $16.83 $1.09 Million - $1.52 Million	-90,093 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$13.83 - $18.78 $1.25 Million - $1.69 Million	90,093 New	90,093 $1.51 Million
Q1 2021 May 13, 2021	SELL	$5.08 - $6.89 $83,921 - $113,822	-16,520 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$5.65 - $7.66 $93,338 - $126,543	16,520 New	16,520 $114,000
Q1 2020 Apr 09, 2020	SELL	$2.83 - $8.44 $49,887 - $148,780	-17,628 Closed	0 $0
Q4 2019 Jan 16, 2020	BUY	$0.93 - $8.58 $16,394 - $151,248	17,628 New	17,628 $151,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.